E-LIB Suche - Ergebnisse für: Hutchings, Martin

1

Long‐term cause‐specific mortality in adolescent and young ..:

Rossetti, Sára ; Juul, Sidsel Jacobsen ; Eriksson, Frank...
British Journal of Haematology. , 2024

Link: https://doi.org/10.1111/..

2

Pulmonary diseases in patients with classical Hodgkin lymph..:

Vandtved, Julie Haugaard ; Øvlisen, Andreas Kiesbye ; Baech, Joachim...
British Journal of Haematology. , 2024

Link: https://doi.org/10.1111/..

3

Epcoritamab monotherapy in patients with relapsed or refrac..:

Linton, Kim M ; Vitolo, Umberto ; Jurczak, Wojciech...
The Lancet Haematology. , 2024

Link: https://doi.org/10.1016/..

4

Ibrutinib combined with immunochemotherapy with or without ..:

Dreyling, Martin ; Doorduijn, Jeanette ; Giné, Eva...
The Lancet. 403 (2024) 10441 - p. 2293-2306 , 2024

Link: https://doi.org/10.1016/..

5

MRD-driven treatment with venetoclax-R2 in mantle cell lymp..:

Jerkeman, Mats ; Kolstad, Arne ; Hutchings, Martin...
Blood Advances. 8 (2024) 2 - p. 407-415 , 2024

Link: https://doi.org/10.1182/..

6

Deep and Durable Responses with Epcoritamab SC Monotherapy ..:

Linton, Kim M ; Jurczak, Wojciech ; Lugtenburg, Pieternella J....
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S33-S34 , 2024

Link: https://doi.org/10.1016/..

7

P1118: LONGER FOLLOW-UP FROM THE PIVOTAL EPCORE NHL-1 TRIAL..:

Jurczak, Wojciech ; Ghesquieres, Herve ; Karimi, Yasmin...
HemaSphere. 7 (2023) S3 - p. e081065c , 2023

Link: https://doi.org/10.1097/..

8

S222: EPCORITAMAB WITH RITUXIMAB + LENALIDOMIDE (R2) PROVID..:

Sureda, Anna ; Falchi, Lorenzo ; Leppa, Sirpa...
HemaSphere. 7 (2023) S3 - p. e5547136 , 2023

Link: https://doi.org/10.1097/..

9

IBCL-474 Epcoritamab + R2 Regimen and Responses in Patients..:

Merryman, Reid W. ; Belada, David ; Sureda, Anna...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S454 , 2023

Link: https://doi.org/10.1016/..

10

Soluble CD163 predicts outcome in both chemoimmunotherapy a..:

Nikkarinen, Anna ; Lokhande, Lavanya ; Amini, Rose-Marie...
Blood Advances. 7 (2023) 18 - p. 5304-5313 , 2023

Link: https://doi.org/10.1182/..

11

Low mortality from COVID‐19 infection in patients with B‐ce..:

Kyvsgaard, Emil R. ; Riley, Caroline ; Clausen, Michael Roost...
British Journal of Haematology. 204 (2023) 1 - p. 356-360 , 2023

Link: https://doi.org/10.1111/..

12

Safety and efficacy of parsaclisib in combination with obin..:

Hamadani, Mehdi ; Coleman, Morton ; Boccia, Ralph...
Hematological Oncology. 41 (2023) 5 - p. 848-857 , 2023

Link: https://doi.org/10.1002/..

13

An artificial intelligence method using FDG PET to predict ..:

Ferrández, Maria C. ; Golla, Sandeep S. V. ; Eertink, Jakoba J....
Scientific Reports. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

14

POSTER: IBCL-474 Epcoritamab + R2 Regimen and Responses in ..:

Merryman, Reid W. ; Belada, David ; Sureda, Anna...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S210 , 2023

Link: https://doi.org/10.1016/..

15

The evolving therapy of DLBCL: Bispecific antibodies:

Hutchings, Martin
Hematological Oncology. 41 (2023) S1 - p. 107-111 , 2023

Link: https://doi.org/10.1002/..